{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:12:07Z","timestamp":1787508727624,"version":"build-2736575974"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["GRF 17127718, GRF 17127215, Seed fund 201611159222"],"award-info":[{"award-number":["GRF 17127718, GRF 17127215, Seed fund 201611159222"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["GRF 17127718, GRF 17127215, Seed fund 201611159222"],"award-info":[{"award-number":["GRF 17127718, GRF 17127215, Seed fund 201611159222"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    More than 1 billion people globally are suffering from hypertension, which is a long-term incurable medical condition that can further lead to dangerous complications and death if left untreated. In earlier studies, the brain-gut peptide secretin (SCT) was found to be able to control blood pressure by its cardiovascular and pulmonary effects. For example, serum SCT in patients with congestive heart failure was one-third of the normal level. These observations strongly suggest that SCT has a causal role in blood pressure control, and in this report, we used constitutive SCT knockout (SCT\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    ) mice and control C57BL\/6N mice to investigate differences in the morphology, function, underlying mechanisms and response to SCT treatment. We found that SCT\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice suffer from systemic and pulmonary hypertension with increased fibrosis in the lungs and heart. Small airway remodelling and pulmonary inflammation were also found in SCT\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice. Serum NO and VEGF levels were reduced and plasma aldosterone levels were increased in SCT\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice. Elevated cardiac aldosterone and decreased VEGF in the lungs were observed in the SCT\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice. More interestingly, SCT replacement in SCT\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice could prevent the development of heart and lung pathologies compared to the untreated group. Taken together, we comprehensively demonstrated the critical role of SCT in the cardiovascular and pulmonary systems and provide new insight into the potential role of SCT in the pathological development of cardiopulmonary and cardiovascular diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-50634-x","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T06:06:02Z","timestamp":1569996362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Loss of secretin results in systemic and pulmonary hypertension with cardiopulmonary pathologies in mice"],"prefix":"10.1038","volume":"9","author":[{"given":"Aung Moe","family":"Zaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathi","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah O. K.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen K. W.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy K. C.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"key":"50634_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","volume":"389","author":"B Zhou","year":"2017","unstructured":"Zhou, B. et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants. The Lancet 389, 37\u201355 (2017).","journal-title":"The Lancet"},{"key":"50634_CR2","unstructured":"World Health Organization. Fact sheet of Cardiovascular diseases (CVDs), https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) (2017)."},{"key":"50634_CR3","unstructured":"Organization, W. H. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. (World Health Organization, 2013)."},{"key":"50634_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1164\/rccm.201203-0383OC","volume":"186","author":"Y Ling","year":"2012","unstructured":"Ling, Y. et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. American journal of respiratory and critical care medicine 186, 790\u2013796 (2012).","journal-title":"American journal of respiratory and critical care medicine"},{"key":"50634_CR5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1136\/heartjnl-2012-301992","volume":"98","author":"G Strange","year":"2012","unstructured":"Strange, G. et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 98, 1805\u20131811 (2012).","journal-title":"Heart"},{"key":"50634_CR6","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.jacc.2004.02.029","volume":"43","author":"M Humbert","year":"2004","unstructured":"Humbert, M. et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. Journal of the American College of Cardiology 43, S13\u2013S24 (2004).","journal-title":"Journal of the American College of Cardiology"},{"key":"50634_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","volume":"14","author":"EM Lau","year":"2017","unstructured":"Lau, E. M., Giannoulatou, E., Celermajer, D. S. & Humbert, M. Epidemiology and treatment of pulmonary arterial hypertension. Nature Reviews Cardiology 14, 603 (2017).","journal-title":"Nature Reviews Cardiology"},{"key":"50634_CR8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2215\/CJN.01060306","volume":"1","author":"DA Calhoun","year":"2006","unstructured":"Calhoun, D. A. Aldosteronism and hypertension. Clinical journal of the American Society of Nephrology 1, 1039\u20131045 (2006).","journal-title":"Clinical journal of the American Society of Nephrology"},{"key":"50634_CR9","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1097\/01.ASN.0000132473.50966.14","volume":"15","author":"EM Freel","year":"2004","unstructured":"Freel, E. M. & Connell, J. M. Mechanisms of hypertension: the expanding role of aldosterone. Journal of the American Society of Nephrology 15, 1993\u20132001 (2004).","journal-title":"Journal of the American Society of Nephrology"},{"key":"50634_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/eci.12286","volume":"44","author":"L Papanastasiou","year":"2014","unstructured":"Papanastasiou, L. et al. Primary aldosteronism in hypertensive patients: clinical implications and target therapy. European journal of clinical investigation 44, 697\u2013706 (2014).","journal-title":"European journal of clinical investigation"},{"key":"50634_CR11","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/j.1460-2075.1991.tb07686.x","volume":"10","author":"T Ishihara","year":"1991","unstructured":"Ishihara, T. et al. Molecular cloning and expression of a cDNA encoding the secretin receptor. The EMBO Journal 10, 1635\u20131641 (1991).","journal-title":"The EMBO Journal"},{"key":"50634_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1165\/rcmb.2004-0035OC","volume":"31","author":"RJ Davis","year":"2004","unstructured":"Davis, R. J. et al. Expression and functions of the duodenal peptide secretin and its receptor in human lung. American journal of respiratory cell and molecular biology 31, 302\u2013308 (2004).","journal-title":"American journal of respiratory cell and molecular biology"},{"key":"50634_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0167-0115(87)90279-5","volume":"19","author":"R Hashimoto","year":"1987","unstructured":"Hashimoto, R. & Kimura, F. The depressor effect of secretin administered either centrally or peripherally in conscious rats. Regulatory peptides 19, 233\u2013242 (1987).","journal-title":"Regulatory peptides"},{"key":"50634_CR14","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0196-9781(02)00092-X","volume":"23","author":"S Gandhi","year":"2002","unstructured":"Gandhi, S., Tsueshita, T., \u00d6ny\u00fcksel, H., Chandiwala, R. & Rubinstein, I. Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo. Peptides 23, 1433\u20131439 (2002).","journal-title":"Peptides"},{"key":"50634_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1113\/expphysiol.2012.070607","volume":"98","author":"E Grossini","year":"2013","unstructured":"Grossini, E., Molinari, C., Morsanuto, V., Mary, D. A. G. & Vacca, G. Intracoronary secretin increases cardiac perfusion and function in anaesthetized pigs through pathways involving \u03b2-adrenoceptors and nitric oxide. Experimental physiology 98, 973\u2013987 (2013).","journal-title":"Experimental physiology"},{"key":"50634_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1152\/ajplegacy.1975.229.5.1365","volume":"229","author":"JW Fara","year":"1975","unstructured":"Fara, J. W. & Madden, K. Effect of secretin and cholecystokinin on small intestinal blood flow distribution. American Journal of Physiology-Legacy Content 229, 1365\u20131370 (1975).","journal-title":"American Journal of Physiology-Legacy Content"},{"key":"50634_CR17","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1053\/j.gastro.2014.02.030","volume":"146","author":"S Glaser","year":"2014","unstructured":"Glaser, S. et al. Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. Gastroenterology 146, 1795\u20131808. e1712 (2014).","journal-title":"Gastroenterology"},{"key":"50634_CR18","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1096\/fj.10-165399","volume":"24","author":"V Lee","year":"2010","unstructured":"Lee, V. et al. An indispensable role of secretin in mediating the osmoregulatory functions of angiotensin II. FASEB J 24, 5024\u20135032 (2010).","journal-title":"FASEB J"},{"key":"50634_CR19","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1096\/fj.201600911R","volume":"31","author":"J Bai","year":"2017","unstructured":"Bai, J. & Chow, B. K. Secretin is involved in sodium conservation through the renin-angiotensin-aldosterone system. The FASEB Journal 31, 1689\u20131697 (2017).","journal-title":"The FASEB Journal"},{"key":"50634_CR20","doi-asserted-by":"crossref","unstructured":"Mak, S. O., Zhang, L. & Chow, B. K. In vivo actions of SCTR\/AT1aR heteromer in controlling Vp expression and release via cFos\/cAMP\/CREB pathway in magnocellular neurons of PVN. The FASEB Journal, fj. 201801732RR (2019).","DOI":"10.1096\/fj.201801732RR"},{"key":"50634_CR21","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/oxfordjournals.eurheartj.a060073","volume":"13","author":"D Nicholls","year":"1992","unstructured":"Nicholls, D. et al. Regulatory peptides in the plasma of patients with chronic cardiac failure at rest and during exercise. European heart journal 13, 1399\u20131404 (1992).","journal-title":"European heart journal"},{"key":"50634_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/heart.89.2.207","volume":"89","author":"H Arakawa","year":"2003","unstructured":"Arakawa, H. et al. Decreased serum vascular endothelial growth factor concentrations in patients with congestive heart failure. Heart 89, 207\u2013208 (2003).","journal-title":"Heart"},{"key":"50634_CR23","first-page":"671","volume":"151","author":"HM DeLisser","year":"1997","unstructured":"DeLisser, H. M. et al. Involvement of endothelial PECAM-1\/CD31 in angiogenesis. The American journal of pathology 151, 671 (1997).","journal-title":"The American journal of pathology"},{"key":"50634_CR24","unstructured":"Mizgerd, J. P. In Seminars in immunology. 123\u2013132 (Elsevier)."},{"key":"50634_CR25","first-page":"183","volume":"86","author":"G Ryan","year":"1977","unstructured":"Ryan, G. & Majno, G. Acute inflammation. American Journal of Pathology 86, 183\u2013276 (1977).","journal-title":"American Journal of Pathology"},{"key":"50634_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara, N., Gerber, H.-P. & LeCouter, J. The biology of VEGF and its receptors. Nature medicine 9, 669 (2003).","journal-title":"Nature medicine"},{"key":"50634_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.humpath.2003.10.025","volume":"35","author":"A Tatsuguchi","year":"2004","unstructured":"Tatsuguchi, A. et al. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Human pathology 35, 488\u2013495 (2004).","journal-title":"Human pathology"},{"key":"50634_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter, A. G. & J\u00e4nicke, R. U. Emerging roles of caspase-3 in apoptosis. Cell death and differentiation 6, 99 (1999).","journal-title":"Cell death and differentiation"},{"key":"50634_CR29","first-page":"375","volume":"52","author":"EM Sitniewska","year":"2000","unstructured":"Sitniewska, E. M., Wi\u015bniewska, R. J. & Wi\u015bniewski, K. Influence of nitric oxide on the cardiovascular action of secretin in intact rats. Part B. Does nitric oxide influence the effect of secretin on isolated heart function? Polish journal of pharmacology 52, 375\u2013381 (2000).","journal-title":"Polish journal of pharmacology"},{"key":"50634_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/01.CCM.0000159563.97092.A7","volume":"33","author":"A Janvier","year":"2005","unstructured":"Janvier, A., Nadeau, S., Baribeau, J. & Perreault, T. Role of vascular endothelial growth factor receptor 1 and vascular endothelial growth factor receptor 2 in the vasodilator response to vascular endothelial growth factor in the neonatal piglet lung. Critical care medicine 33, 860\u2013866 (2005).","journal-title":"Critical care medicine"},{"key":"50634_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1476-5381.2009.00396.x","volume":"158","author":"C Van Hove","year":"2009","unstructured":"Van Hove, C. et al. Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells. British journal of pharmacology 158, 920\u2013930 (2009).","journal-title":"British journal of pharmacology"},{"key":"50634_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/377239a0","volume":"377","author":"PL Huang","year":"1995","unstructured":"Huang, P. L. et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239 (1995).","journal-title":"Nature"},{"key":"50634_CR33","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1073\/pnas.93.23.13176","volume":"93","author":"EG Shesely","year":"1996","unstructured":"Shesely, E. G. et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences 93, 13176\u201313181 (1996).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"50634_CR34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/01.HYP.37.3.845","volume":"37","author":"AH El-Gharbawy","year":"2001","unstructured":"El-Gharbawy, A. H. et al. Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension 37, 845\u2013850 (2001).","journal-title":"Hypertension"},{"key":"50634_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1161\/01.HYP.0000154364.00763.d5","volume":"45","author":"CE Grim","year":"2005","unstructured":"Grim, C. E. et al. Hyperaldosteronism and hypertension: ethnic differences. Hypertension 45, 766\u2013772 (2005).","journal-title":"Hypertension"},{"key":"50634_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00461-9","volume":"7","author":"H Gu","year":"2017","unstructured":"Gu, H. et al. Salt-dependent blood pressure in human aldosterone synthase-transgenic mice. Scientific reports 7, 492 (2017).","journal-title":"Scientific reports"},{"key":"50634_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.yjmcc.2005.04.001","volume":"39","author":"JG Burniston","year":"2005","unstructured":"Burniston, J. G., Saini, A., Tan, L.-B. & Goldspink, D. F. Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. Journal of molecular and cellular cardiology 39, 395\u2013399 (2005).","journal-title":"Journal of molecular and cellular cardiology"},{"key":"50634_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","volume":"32","author":"P Lijnen","year":"2000","unstructured":"Lijnen, P. & Petrov, V. Induction of cardiac fibrosis by aldosterone. Journal of molecular and cellular cardiology 32, 865\u2013879 (2000).","journal-title":"Journal of molecular and cellular cardiology"},{"key":"50634_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/01.HYP.35.1.324","volume":"35","author":"CJ Hanke","year":"2000","unstructured":"Hanke, C. J., O\u2019Brien, T., Pritchard, K. A. Jr & Campbell, W. B. Inhibition of adrenal cell aldosterone synthesis by endogenous nitric oxide release. Hypertension 35, 324\u2013328 (2000).","journal-title":"Hypertension"},{"key":"50634_CR40","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0735-1097(02)02860-7","volume":"41","author":"TM Seccia","year":"2003","unstructured":"Seccia, T. M. et al. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. Journal of the American College of Cardiology 41, 666\u2013673 (2003).","journal-title":"Journal of the American College of Cardiology"},{"key":"50634_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/cvr\/cvt181","volume":"100","author":"A Kazakov","year":"2013","unstructured":"Kazakov, A. et al. Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis. Cardiovascular research 100, 211\u2013221 (2013).","journal-title":"Cardiovascular research"},{"key":"50634_CR42","doi-asserted-by":"publisher","first-page":"H474","DOI":"10.1152\/ajpheart.00922.2006","volume":"293","author":"N Shimojo","year":"2007","unstructured":"Shimojo, N. et al. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology 293, H474\u2013H481 (2007).","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"50634_CR43","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1096\/fj.08-125302","volume":"23","author":"S Messaoudi","year":"2009","unstructured":"Messaoudi, S., Milliez, P., Samuel, J.-L. & Delcayre, C. Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density. The FASEB Journal 23, 2176\u20132185 (2009).","journal-title":"The FASEB Journal"},{"key":"50634_CR44","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.jacc.2004.09.044","volume":"44","author":"M Krenz","year":"2004","unstructured":"Krenz, M. & Robbins, J. Impact of beta-myosin heavy chain expression on cardiac function during stress. Journal of the American College of Cardiology 44, 2390\u20132397 (2004).","journal-title":"Journal of the American College of Cardiology"},{"key":"50634_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","volume":"186","author":"E Stacher","year":"2012","unstructured":"Stacher, E. et al. Modern age pathology of pulmonary arterial hypertension. American journal of respiratory and critical care medicine 186, 261\u2013272 (2012).","journal-title":"American journal of respiratory and critical care medicine"},{"key":"50634_CR46","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCRESAHA.110.236927","volume":"109","author":"R Tamosiuniene","year":"2011","unstructured":"Tamosiuniene, R. et al. Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circulation research 109, 867\u2013879 (2011).","journal-title":"Circulation research"},{"key":"50634_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1378\/chest.11-0793","volume":"141","author":"LC Price","year":"2012","unstructured":"Price, L. C. et al. Inflammation in pulmonary arterial hypertension. Chest 141, 210\u2013221 (2012).","journal-title":"Chest"},{"key":"50634_CR48","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"RT Schermuly","year":"2005","unstructured":"Schermuly, R. T. et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. The Journal of clinical investigation 115, 2811\u20132821 (2005).","journal-title":"The Journal of clinical investigation"},{"key":"50634_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-125","volume":"7","author":"S Mukhopadhyay","year":"2006","unstructured":"Mukhopadhyay, S., Hoidal, J. R. & Mukherjee, T. K. Role of TNF\u03b1 in pulmonary pathophysiology. Respiratory research 7, 125 (2006).","journal-title":"Respiratory research"},{"key":"50634_CR50","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1152\/japplphysiol.00083.2002","volume":"93","author":"M Fujita","year":"2002","unstructured":"Fujita, M. et al. Pulmonary hypertension in TNF-\u03b1-overexpressing mice is associated with decreased VEGF gene expression. Journal of Applied Physiology 93, 2162\u20132170 (2002).","journal-title":"Journal of Applied Physiology"},{"key":"50634_CR51","doi-asserted-by":"publisher","first-page":"C854","DOI":"10.1152\/ajpcell.1992.262.4.C854","volume":"262","author":"P Marsden","year":"1992","unstructured":"Marsden, P. & Brenner, B. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. American Journal of Physiology-Cell Physiology 262, C854\u2013C861 (1992).","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"50634_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jaci.2014.05.049","volume":"134","author":"SN Georas","year":"2014","unstructured":"Georas, S. N. & Rezaee, F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. Journal of Allergy and Clinical Immunology 134, 509\u2013520 (2014).","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"50634_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ni.3045","volume":"16","author":"JA Whitsett","year":"2015","unstructured":"Whitsett, J. A. & Alenghat, T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nature immunology 16, 27 (2015).","journal-title":"Nature immunology"},{"key":"50634_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/08958370701866412","volume":"20","author":"M Suzuki","year":"2008","unstructured":"Suzuki, M. et al. Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients. Inhalation toxicology 20, 349\u2013359 (2008).","journal-title":"Inhalation toxicology"},{"key":"50634_CR55","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2222.2004.1917.x","volume":"34","author":"RK Kumar","year":"2004","unstructured":"Kumar, R. K., Herbert, C. & Foster, P. S. Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clinical & Experimental Allergy 34, 567\u2013575 (2004).","journal-title":"Clinical & Experimental Allergy"},{"key":"50634_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4236\/ojrd.2012.21002","volume":"2","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. Regulation of nitric oxide by cigarette smoke in airway cells. Open Journal of Respiratory Diseases 2, 9 (2012).","journal-title":"Open Journal of Respiratory Diseases"},{"key":"50634_CR57","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI36136","volume":"119","author":"L Farkas","year":"2009","unstructured":"Farkas, L. et al. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. The Journal of clinical investigation 119, 1298\u20131311 (2009).","journal-title":"The Journal of clinical investigation"},{"key":"50634_CR58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1165\/rcmb.2012-0077OC","volume":"47","author":"S Mizuno","year":"2012","unstructured":"Mizuno, S. et al. Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization. American journal of respiratory cell and molecular biology 47, 679\u2013687 (2012).","journal-title":"American journal of respiratory cell and molecular biology"},{"key":"50634_CR59","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/2045-8932.105031","volume":"2","author":"MR Nicolls","year":"2012","unstructured":"Nicolls, M. R. et al. New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis. Pulmonary circulation 2, 434\u2013442 (2012).","journal-title":"Pulmonary circulation"},{"key":"50634_CR60","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/CIRCULATIONAHA.112.094722","volume":"126","author":"BA Maron","year":"2012","unstructured":"Maron, B. A. et al. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation 126, 963\u2013974 (2012).","journal-title":"Circulation"},{"key":"50634_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-10-95","volume":"10","author":"S Sakao","year":"2009","unstructured":"Sakao, S., Tatsumi, K. & Voelkel, N. F. Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respiratory research 10, 95 (2009).","journal-title":"Respiratory research"},{"key":"50634_CR62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/09629350210311","volume":"11","author":"P Akarasereenont","year":"2002","unstructured":"Akarasereenont, P., Techatraisak, K., Thaworn, A. & Chotewuttakorn, S. The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase. Mediators of inflammation 11, 17\u201322 (2002).","journal-title":"Mediators of inflammation"},{"key":"50634_CR63","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1203\/01.pdr.0000200798.79840.3d","volume":"59","author":"H Lukkarinen","year":"2006","unstructured":"Lukkarinen, H. et al. Inhibition of COX-2 aggravates neutrophil migration and pneumocyte apoptosis in surfactant-depleted rat lungs. Pediatric research 59, 412 (2006).","journal-title":"Pediatric research"},{"key":"50634_CR64","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1165\/ajrcmb\/9.4.429","volume":"9","author":"MA Zamora","year":"1993","unstructured":"Zamora, M. A., Dempsey, E. C., Walchak, S. J. & Stelzner, T. J. BQ-123, an ETA receptor antagonist, inhibits endothelin-l-mediated proliferation of human pulmonary artery smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology 9, 429\u2013433 (1993).","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"50634_CR65","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","volume":"35","author":"Y Sun","year":"1997","unstructured":"Sun, Y., Ramires, F. J. & Weber, K. T. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovascular research 35, 138\u2013147 (1997).","journal-title":"Cardiovascular research"},{"key":"50634_CR66","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"Brown, N. J. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nature Reviews Nephrology 9, 459 (2013).","journal-title":"Nature Reviews Nephrology"},{"key":"50634_CR67","doi-asserted-by":"publisher","first-page":"H2069","DOI":"10.1152\/ajpheart.00805.2010","volume":"299","author":"DM Tabima","year":"2010","unstructured":"Tabima, D. M., Hacker, T. A. & Chesler, N. C. Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops. American Journal of Physiology-Heart and Circulatory Physiology 299, H2069\u2013H2075 (2010).","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"50634_CR68","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/nprot.2014.113","volume":"9","author":"AJ Smith","year":"2014","unstructured":"Smith, A. J. et al. Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart. Nature protocols 9, 1662 (2014).","journal-title":"Nature protocols"},{"key":"50634_CR69","doi-asserted-by":"crossref","unstructured":"Virag, J. A. & Lust, R. M. Coronary artery ligation and intramyocardial injection in a murine model of infarction. JoVE (Journal of Visualized Experiments), e2581 (2011).","DOI":"10.3791\/2581"},{"key":"50634_CR70","doi-asserted-by":"publisher","first-page":"H2417","DOI":"10.1152\/ajpheart.01170.2005","volume":"290","author":"JL Grobe","year":"2006","unstructured":"Grobe, J. L., Mecca, A. P., Mao, H. & Katovich, M. J. Chronic angiotensin-(1\u20137) prevents cardiac fibrosis in DOCA-salt model of hypertension. American Journal of Physiology-Heart and Circulatory Physiology 290, H2417\u2013H2423 (2006).","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"50634_CR71","first-page":"131","volume":"12","author":"E Weibel","year":"1963","unstructured":"Weibel, E. Principles and methods for the morphometric study of the lung and other organs. Lab Invest 12, 131\u2013155 (1963).","journal-title":"Lab Invest"},{"key":"50634_CR72","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1172\/JCI16440","volume":"111","author":"Y-G Kwak","year":"2003","unstructured":"Kwak, Y.-G. et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. The Journal of clinical investigation 111, 1083\u20131092 (2003).","journal-title":"The Journal of clinical investigation"},{"key":"50634_CR73","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1194\/jlr.M038042","volume":"55","author":"R Sekar","year":"2014","unstructured":"Sekar, R. & Chow, B. K. Lipolytic actions of secretin in mouse adipocytes. Journal of lipid research 55, 190\u2013200 (2014).","journal-title":"Journal of lipid research"},{"key":"50634_CR74","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang, R. M. et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography 18, 1440\u20131463 (2005).","journal-title":"Journal of the American Society of Echocardiography"},{"key":"50634_CR75","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.106.681718","volume":"115","author":"SI Said","year":"2007","unstructured":"Said, S. I. et al. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. Circulation 115, 1260 (2007).","journal-title":"Circulation"},{"key":"50634_CR76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1152\/physiolgenomics.2001.5.2.89","volume":"5","author":"GM Butz","year":"2001","unstructured":"Butz, G. M. & Davisson, R. L. Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiological genomics 5, 89\u201397 (2001).","journal-title":"Physiological genomics"},{"key":"50634_CR77","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1096\/fj.13-247536","volume":"28","author":"R Sekar","year":"2014","unstructured":"Sekar, R. & Chow, B. K. Secretin receptor-knockout mice are resistant to high-fat diet-induced obesity and exhibit impaired intestinal lipid absorption. The FASEB Journal 28, 3494\u20133505 (2014).","journal-title":"The FASEB Journal"},{"key":"50634_CR78","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1128\/MCB.01088-06","volume":"27","author":"JY Chu","year":"2007","unstructured":"Chu, J. Y. et al. Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption. Molecular and cellular biology 27, 2499\u20132511, https:\/\/doi.org\/10.1128\/MCB.01088-06 (2007).","journal-title":"Molecular and cellular biology"},{"key":"50634_CR79","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/9780470942390.mo110201","volume":"2","author":"F Daubeuf","year":"2012","unstructured":"Daubeuf, F. & Frossard, N. Performing bronchoalveolar lavage in the mouse. Current protocols in mouse biology 2, 167\u2013175 (2012).","journal-title":"Current protocols in mouse biology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50634-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:09:17Z","timestamp":1671268157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50634-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50634"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50634-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14211"}}